# Publisher Correction: Author Correction: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial

**Authors:** Hongli Gong, Shu Tian, Hao Ding, Lei Tao, Li Wang, Jie Wang, Tian Wang, Xiaohui Yuan, Yu Heng, Ming Zhang, Yong Shi, Chengzhi Xu, Chunping Wu, Shengzi Wang, Liang Zhou

PMC · DOI: 10.1038/s41467-024-52656-0 · 2024-09-24

## Full-text entities

- **Diseases:** hypopharyngeal carcinoma (MESH:D007012)

---
Source: https://tomesphere.com/paper/PMC11424632